Beng Yang

2.5k total citations · 2 hit papers
27 papers, 1.8k citations indexed

About

Beng Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Beng Yang has authored 27 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Beng Yang's work include MicroRNA in disease regulation (8 papers), RNA modifications and cancer (7 papers) and Cancer-related gene regulation (6 papers). Beng Yang is often cited by papers focused on MicroRNA in disease regulation (8 papers), RNA modifications and cancer (7 papers) and Cancer-related gene regulation (6 papers). Beng Yang collaborates with scholars based in China, Madagascar and United States. Beng Yang's co-authors include Jian Wu, Shusen Zheng, Junru Chen, Haiyang Xie, Rongliang Tong, Yunhao Chen, Lin Zhou, Yanpeng Zhang, Chuanhui Peng and Bin He and has published in prestigious journals such as Hepatology, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Beng Yang

26 papers receiving 1.8k citations

Hit Papers

WTAP facilitates progression of hepatocellular carcinoma ... 2019 2026 2021 2023 2019 2023 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1
    2019 479 citations Yunhao Chen, Chuanhui Peng et al. Molecular Cancer profile →
  2. Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion
    2023 90 citations Da Man, Jiahua Lu et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beng Yang China 18 1.4k 890 190 188 185 27 1.8k
Rongliang Tong China 19 734 0.5× 430 0.5× 136 0.7× 128 0.7× 267 1.4× 33 1.3k
Lei Sun China 23 1.6k 1.2× 755 0.8× 167 0.9× 90 0.5× 50 0.3× 66 2.3k
Michael J. Lukey United States 15 1.3k 0.9× 1.0k 1.1× 245 1.3× 145 0.8× 104 0.6× 21 2.2k
Jie Mei China 26 1.0k 0.8× 646 0.7× 403 2.1× 393 2.1× 151 0.8× 127 2.0k
Bing Song China 26 1.5k 1.1× 986 1.1× 291 1.5× 349 1.9× 326 1.8× 68 2.8k
Zhiwen Fan China 29 835 0.6× 222 0.2× 170 0.9× 154 0.8× 368 2.0× 83 2.0k
Ricardo Gândara United Kingdom 14 876 0.6× 631 0.7× 387 2.0× 58 0.3× 184 1.0× 14 1.5k
Pinghua Yang China 25 697 0.5× 603 0.7× 284 1.5× 193 1.0× 67 0.4× 66 1.7k

Countries citing papers authored by Beng Yang

Since Specialization
Citations

This map shows the geographic impact of Beng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beng Yang more than expected).

Fields of papers citing papers by Beng Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beng Yang. The network helps show where Beng Yang may publish in the future.

Co-authorship network of co-authors of Beng Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Beng Yang. A scholar is included among the top collaborators of Beng Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beng Yang. Beng Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Cheng, et al.. (2025). The effect of TIM1+ Breg cells in liver ischemia-reperfusion injury. Cell Death and Disease. 16(1). 171–171. 1 indexed citations
3.
Sun, Yujing, Xiaoyu Weng, Wei Chen, et al.. (2024). MYBBP1A‑mediated IGFBP4 promoter methylation promotes epithelial‑mesenchymal transition and metastasis through activation of NOTCH pathway in liver cancer. International Journal of Oncology. 66(1). 2 indexed citations
4.
Hu, Xin, Guanrong Chen, Qiyang Cheng, et al.. (2024). Integrated Multiomics Reveals Silencing of has_circ_0006646 Promotes TRIM21‐Mediated NCL Ubiquitination to Inhibit Hepatocellular Carcinoma Metastasis. Advanced Science. 11(16). e2306915–e2306915. 14 indexed citations
5.
Ru, Junnan, Jiahua Lu, Bo Ding, et al.. (2023). IRGM is a novel regulator of PD-L1 via promoting S6K1-mediated phosphorylation of YBX1 in hepatocellular carcinoma. Cancer Letters. 581. 216495–216495. 24 indexed citations
6.
Man, Da, Jiahua Lu, Yifan Jiang, et al.. (2023). Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion. Advanced Science. 10(15). e2206669–e2206669. 90 indexed citations breakdown →
7.
Tong, Rongliang, Xiaode Feng, Zhenan Ling, et al.. (2023). Co‐Delivery of siNRF2 and Sorafenib by a “Click” Dual Functioned Hyperbranched Nanocarrier for Synergistically Inducing Ferroptosis in Hepatocellular Carcinoma. Small. 20(21). e2307273–e2307273. 17 indexed citations
8.
Wu, Yichao, Kangchen Chen, Ronggao Chen, et al.. (2023). Gp78 deficiency in hepatocytes alleviates hepatic ischemia-reperfusion injury via suppressing ACSL4-mediated ferroptosis. Cell Death and Disease. 14(12). 810–810. 23 indexed citations
9.
Chen, Wei, Junnan Ru, Da Man, et al.. (2022). MiR-652-3p promotes malignancy and metastasis of cancer cells via inhibiting TNRC6A in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 640. 1–11. 1 indexed citations
10.
11.
Yang, Beng, et al.. (2020). Influence of near ground phase vortex on the correction of adaptive optics. 37(4). 466. 2 indexed citations
12.
Chen, Junru, Chaofeng Ding, Yunhao Chen, et al.. (2020). ACSL4 promotes hepatocellular carcinoma progression via c-Myc stability mediated by ERK/FBW7/c-Myc axis. Oncogenesis. 9(4). 42–42. 71 indexed citations
13.
Chen, Yunhao, Yanchun Zhao, Junru Chen, et al.. (2020). ALKBH5 suppresses malignancy of hepatocellular carcinoma via m6A-guided epigenetic inhibition of LYPD1. Molecular Cancer. 19(1). 123–123. 205 indexed citations
14.
Chen, Yunhao, Chuanhui Peng, Junru Chen, et al.. (2019). WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Molecular Cancer. 18(1). 127–127. 479 indexed citations breakdown →
15.
Wu, Jingbang, Beng Yang, Yanpeng Zhang, et al.. (2019). miR-424-5p represses the metastasis and invasion of intrahepatic cholangiocarcinoma by targeting ARK5. International Journal of Biological Sciences. 15(8). 1591–1599. 54 indexed citations
16.
Sun, Weijian, Yongdong Yi, Yaxin Zhao, et al.. (2019). Nrf2-miR-129-3p-mTOR Axis Controls an miRNA Regulatory Network Involved in HDACi-Induced Autophagy. Molecular Therapy. 27(5). 1039–1050. 40 indexed citations
17.
Sun, Weijian, Bin He, Beng Yang, et al.. (2018). Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinoma. Laboratory Investigation. 98(6). 734–744. 42 indexed citations
18.
Sun, Weijian, Bin He, Beng Yang, et al.. (2017). Autophagy blockade enhances the anti-cancer effect of Romidepsin in gastric cancer. Translational Cancer Research. 6(6). 1313–1320. 1 indexed citations
19.
Chen, Xuerui, Rongliang Tong, Beng Yang, et al.. (2017). MOF Nanoparticles with Encapsulated Autophagy Inhibitor in Controlled Drug Delivery System for Antitumor. ACS Applied Materials & Interfaces. 10(3). 2328–2337. 295 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongliang Tong Breakdown of academic impact, for papers by Lei Sun Breakdown of academic impact, for papers by Michael J. Lukey Breakdown of academic impact, for papers by Jie Mei Breakdown of academic impact, for papers by Bing Song Breakdown of academic impact, for papers by Zhiwen Fan Breakdown of academic impact, for papers by Ricardo Gândara Breakdown of academic impact, for papers by Pinghua Yang
Rankless by CCL
2026